ABOUT THERMO FISHER SCIENTIFIC
Thermo Fisher is a leading global provider of bioprocessing solutions. We purposefully connect our capabilities across all phases of the drug lifecycle, accelerating our customers’ pace to patient impact. With our comprehensive portfolio of products and services we are a dedicated partner throughout the biological drug development journey.
Key Capabilities:
- Media and buffer preparation
- Cell expansion
- Cell culture production
- Harvest
- Capture and polish chromatography
- Viral inactivation, filtration, and QC testing
- Bulk storage, fill, and finish
- cGMP chemicals and supply chain services
- Expert professional support to meet process, scale, quality, and regulatory requirements
CONTACT INFORMATION
Thermo Fisher Scientific
7305 Executive Way
Frederick, MD 21704
UNITED STATES
Contact: Hunter Tuck
FEATURED SOLUTIONS
-
Explore how strategic resin and buffer selection enhances AAV purification efficiency, from affinity capture that reduces processing steps to anion exchange methods that separate full capsids.
-
Learn how optimized resin and buffer combinations improve mAb purification efficiency, helping you achieve stringent quality standards while extending resin lifetime and reducing costs.
-
Optimize mRNA purification yield and purity with compatible resin and buffer combinations for therapeutic applications, supported by cGMP-compliant chemical supply chains.
-
Leverage diverse, ready-to-use media and feed formulations to quickly identify the optimal nutrient balance for your CHO cell line, accelerating bioproduction success and subsequent process optimization.
-
Leverage custom media development services to optimize formulations for increased titers, quality, and manufacturability. Choose between traditional or multi-omics workflows to meet your cell line's specific needs.
-
Maintain material quality and integrity with storage facilities compliant with ISO 9001, cGMP, and GDP standards. Features include real-time temperature control and HAZ-class segregation.
-
Effective inventory management ensures the quality and traceability of raw materials, supports regulatory compliance, and enables operational savings. Learn how to secure your supply chain and reduce stockouts.
-
Transitioning to biobased materials in cell culture reduces reliance on virgin fossil fuel feedstocks and helps meet Scope 3 emission reduction goals, offering a sustainable path for biomanufacturing.
FEATURED INSIGHTS
-
Discover four essential bioprocess scale-up criteria and how each balances hydrodynamics, shear, and mass transfer across manufacturing scales.
-
Explore how a unified bioreactor design enables consistent process performance from bench to production, minimizing scale-up risk while maintaining cell growth and yield.
-
Amid the mRNA and oligonucleotide therapeutic boom, sponsors and manufacturers are exploring how to make critical raw materials—capping agents, lipid nanoparticles, and RNA polymerase—more effective.
-
Residual host-cell DNA quantitation requires sensitive, well-validated analytical workflows to ensure accurate impurity control, process understanding, and regulatory compliance in complex biologics.
-
The most common contamination risks in cell therapy manufacturing are open processes that leverage different products, inflexible instruments, labor intensive workflows, lack of in-line monitoring, and zero failure tolerance.
-
Process robust mAb production requires understanding scale dependent cell environments, leveraging predictive models, and pursuing data driven control to minimize variability, optimize quality, and ensure reliable technology transfer across biomanufacturing scales.
-
Multispecific antibodies are a newer class of cancer therapeutics addressing tumor complexity. Learn about the design, manufacturing, and regulatory challenges and integrated solutions accelerating their development.
-
Industry 5.0 represents the next generation of bioproduction—the Adaptive Plant—where human expertise is empowered by AI-enabled insights, autonomous systems, and strategic collaboration.